Cardiovascular medicine – BJC TV https://tv.bjcardio.co.uk Short video updates for cardiologists Wed, 23 Sep 2026 10:17:35 +0000 en-GB hourly 1 https://wordpress.org/?v=7.1.2 https://tv.bjcardio.co.uk/wp-content/uploads/2023/06/cropped-favicon-32x32.png Cardiovascular medicine – BJC TV https://tv.bjcardio.co.uk 32 32 Highlights from the ESC Congress 2026 https://tv.bjcardio.co.uk/cardiovascular-medicine/highlights-from-the-esc-congress-2026/ Wed, 23 Sep 2026 08:41:20 +0000 https://tv.bjcardio.co.uk/?p=12107 Learning objectives:
  • Discover the latest ESC guidance on heart failure, and the first-ever ESC guidance on cardiovascular disease and chronic kidney disease.
  • Explore new evidence on prevention across the life course, including statin therapy and sustained blood-pressure control to reduce cardiovascular risk.
  • Learn about trials into potential of transcatheter treatment for severe tricuspid regurgitation, and aficamten for symptomatic non-obstructive hypertrophic cardiomyopathy, and much more.
Speakers

Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospitals Dorset
Dr Patrick Hurley, Cardiology Registrar, University Hospitals Dorset

]]> Cardiovascular disease modern service framework – Implementation and practical considerations for primary care https://tv.bjcardio.co.uk/cardiovascular-medicine/cardiovascular-disease-modern-service-framework-implementation-and-practical-considerations-for-primary-care/ Tue, 15 Sep 2026 11:01:47 +0000 https://tv.bjcardio.co.uk/?p=12077 Learning objectives:

  • Explore the implications of this new, broad and holistic framework  

  • Understand that early and pro-active diagnosis is a key factor 

  • Discover the 12 key priorities outlined in the guidelines 

  • Learn the new ABCDE Approach 

Speakers

Beverley Bostock RN MSc MA Queen’s Nurse  President-Elect Primary Care Cardiovascular Society  

Professor Raj Thakkar BSc(Hons) MBBS MRCGP MRCP(UK)FRCP(Edin) President, Primary Care Cardiovascular Society, UK 

]]> BEACON series – Episode 1: Primary prevention of CVD – QRISK® <10% https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-1-primary-prevention-of-cvd-qrisk-10/ Tue, 01 Sep 2026 08:12:00 +0000 https://tv.bjcardio.co.uk/?p=11855 ® scores may underestimate their true risk. The faculty will examine how to identify patients who would benefit from earlier intervention, interpret lifetime versus 10-year cardiovascular risk, and optimise lipid-lowering and cardiovascular risk reduction strategies in line with current evidence and guidelines.]]> Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CVD = cardiovascular disease

]]> BEACON series – Episode 2: Secondary prevention post-MI and peripheral artery disease https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-2-secondary-prevention-post-mi-and-peripheral-artery-disease/ Tue, 01 Sep 2026 08:11:00 +0000 https://tv.bjcardio.co.uk/?p=11859 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; LDL-C = low-density lipoprotein cholesterol; MI = myocardial infarction

]]> BEACON series – Episode 3: CVD risk management in type 2 diabetes https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-3-cvd-risk-management-in-type-2-diabetes/ Tue, 01 Sep 2026 08:10:00 +0000 https://tv.bjcardio.co.uk/?p=11862 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CVD = cardiovascular disease

]]> BEACON series – Episode 4: Type 2 diabetes and chronic kidney disease https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-4-type-2-diabetes-and-chronic-kidney-disease/ Tue, 01 Sep 2026 08:09:00 +0000 https://tv.bjcardio.co.uk/?p=11864 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CKD = chronic kidney disease

]]> Heart failure in black patients – exploring genes and cardiac amyloidosis https://tv.bjcardio.co.uk/cardiovascular-medicine/heart-failure-in-black-patients-exploring-genes-and-cardiac-amyloidosis/ Wed, 22 Jul 2026 16:12:45 +0000 https://tv.bjcardio.co.uk/?p=11908

Learning objectives:

  • To understand the difference between Transthyretin Amyloidosis (ATTR) and Amyloid Light-chain Amyloidosis (AL)
  • To learn about the hereditary subtype ATTR V122I and how it affects patients of black ethnicity
  • To develop an understanding of the challenges faced in diagnosing and treating this condition
  • To gain awareness of ways to support black patients with hereditary ATTR and those who carry the gene
  • To feel empowered to diagnose ATTR and develop a knowledge of the condition to implement in clinical practise in a culturally sensitive way.

 

Speaker

Dr Jason Dungu PhD, FRCP, FESC

Consultant Cardiologist and Essex ICC Lead, Essex Cardiothoracic Centre, Mid & South Essex NHS Foundation Trust Honorary Senior Clinical Lecturer, Anglia Ruskin University 

]]> Beyond silos: leading the future of cardio-renal-metabolic care https://tv.bjcardio.co.uk/cardiovascular-medicine/beyond-silos-leading-the-future-of-cardio-renal-metabolic-care/ Fri, 03 Jul 2026 16:33:12 +0000 https://tv.bjcardio.co.uk/?p=12118

In this talk, Beverley called for nurses to keep smashing cardiovascular-renal-metabolic (CVRM) silos and to collaboratively think across CVRM care. She described the overlapping conditions as “different sides of the same coin”.

Speaker

Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire

]]> Key differences between Kerendia▼ (finerenone) and steroidal MRAs https://tv.bjcardio.co.uk/cardiovascular-medicine/key-differences-between-kerendia-and-steroidal-mras/ Fri, 19 Jun 2026 14:01:00 +0000 https://tv.bjcardio.co.uk/?p=11756 1–4]]> Prescribing information and adverse event reporting information for Kerendia®▼(finerenone) can be found here.

Featuring

Professor John McMurray, Professor of Cardiology (Cardiology & Metabolic Health), School of Cardiovascular and Metabolic Health
Professor Richard Hobbs, Mercian Professor of Primary Care, University of Oxford

References
  1. Piccirillo F, Liporace P, Nusca A et al. Effects of finerenone on cardiovascular and chronic kidney diseases: a new weapon against cardiorenal morbidity and mortality‑a comprehensive review. J Cardiovasc Dev Dis 2023;10:236.
  2. Kolkhof P, Jaisser F, Kim S-Y et al. Steroidal and novel non‑steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside. In Bauersachs J et al (eds): Heart failure. Springer International Publishing, Cham, Switzerland, 2017:271–305.
  3. Spironolactone Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/12015/smpc#gref.
  4. Eplerenone Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/8810/smpc.

DOWNLOAD OUR DOSING GUIDE

]]> Exercise in cardiomyopathy: What happens after the consultation? https://tv.bjcardio.co.uk/cardiovascular-medicine/exercise-in-cardiomyopathy-what-happens-after-the-consultation/ Fri, 29 May 2026 10:18:16 +0000 https://tv.bjcardio.co.uk/?p=11778

Learning objectives: 

  • To understand that exercise is possible for nearly all cardiomyopathy patients
  • To learn successful ways to tailor exercise for individual patients  
  • To develop an understanding of the ACTIVE clinical approach and the four pillars of cardiovascular rehabilitation
  • To gain awareness of how to support patients safely with practical exercise prescription  
  • To feel inspired to help patients manage their cardiovascular health with confidence  

 

Speaker: Shane Purcell Clinical Exercise Physiologist, Imperial College Healthcare NHS Trust

 

]]>